These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8672826)

  • 21. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
    Shetty HG; Backhouse G; Bentley DP; Routledge PA
    Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.
    Pengo V; Banzato A; Garelli E; Zasso A; Biasiolo A
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):739-41. PubMed ID: 8292723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose vitamin K1 versus short-term with holding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol. A retrospective comparative study.
    Ortín M; Olalla J; Marco F; Velasco N
    Haemostasis; 1998; 28(2):57-61. PubMed ID: 10087429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
    Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
    Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial.
    Kurnik D; Loebstein R; Rabinovitz H; Austerweil N; Halkin H; Almog S
    Thromb Haemost; 2004 Nov; 92(5):1018-24. PubMed ID: 15543329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Intravenous Versus Subcutaneous Phytonadione on Length of Stay for Patients in Need of Urgent Warfarin Reversal.
    Mottice BL; Soric MM; Legros E
    Am J Ther; 2016; 23(2):e345-9. PubMed ID: 25461960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review.
    Fugate SE; Nichols CM; Cudd LA
    Pharmacotherapy; 2004 Sep; 24(9):1213-20. PubMed ID: 15460182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of excessive anticoagulation with low-dose oral vitamin K1.
    Weibert RT; Le DT; Kayser SR; Rapaport SI
    Ann Intern Med; 1997 Jun; 126(12):959-62. PubMed ID: 9182473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-Acting Oral Anticoagulants and Warfarin-Associated Intracerebral Hemorrhage Protocol Reduces Timing of Door to Correction Interventions.
    Olivier RC; Gleeson D; Skinner C; Cacciata M; Wickman M
    J Neurosci Nurs; 2019 Apr; 51(2):89-94. PubMed ID: 30801446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content.
    Booth SL; Charnley JM; Sadowski JA; Saltzman E; Bovill EG; Cushman M
    Thromb Haemost; 1997 Mar; 77(3):504-9. PubMed ID: 9066002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation.
    Whitling AM; Bussey HI; Lyons RM
    Arch Intern Med; 1998 Oct; 158(19):2136-40. PubMed ID: 9801181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.
    Schubiger G; Stocker C; Bänziger O; Laubscher B; Zimmermann H
    Eur J Pediatr; 1999 Jul; 158(7):599-602. PubMed ID: 10412823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with oral versus intravenous vitamin K for warfarin reversal.
    Meehan R; Tavares M; Sweeney J
    Transfusion; 2013 Mar; 53(3):491-8; quiz 490. PubMed ID: 22738309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of oral vitamin K use by anticoagulation clinics.
    Libby EN; Garcia DA
    Arch Intern Med; 2002 Sep; 162(16):1893-6. PubMed ID: 12196089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.